Jacob DA - Search Results

1

Induction of apoptosis and down-regulation of Bcl-XL in cancer cells by a novel small molecule, 2[[3-(2,3-dichlorophenoxy)propyl]amino]ethanol.

Wu S, Zhu H, Gu J, Zhang L, Teraishi F, Davis JJ, Jacob DA, Fang B. Wu S, et al. Among authors: jacob da. Cancer Res. 2004 Feb 1;64(3):1110-3. doi: 10.1158/0008-5472.can-03-2790. Cancer Res. 2004. PMID: 14871845

2

Overcoming acquired resistance to TRAIL by chemotherapeutic agents and calpain inhibitor I through distinct mechanisms.

Zhu H, Zhang L, Huang X, Davis JJ, Jacob DA, Teraishi F, Chiao P, Fang B. Zhu H, et al. Among authors: jacob da. Mol Ther. 2004 May;9(5):666-73. doi: 10.1016/j.ymthe.2004.02.007. Mol Ther. 2004. PMID: 15120327 Free article.

3

Lack of p38 MAP kinase activation in TRAIL-resistant cells is not related to the resistance to TRAIL-mediated cell death.

Zhang L, Zhu H, Davis JJ, Jacob D, Wu S, Teraishi F, Gutierrez A, Wang Y, Fang B. Zhang L, et al. Cancer Biol Ther. 2004 Mar;3(3):296-301. doi: 10.4161/cbt.3.3.696. Epub 2004 Mar 16. Cancer Biol Ther. 2004. PMID: 14749540 Free article.

4

Induction of S-phase arrest and p21 overexpression by a small molecule 2[[3-(2,3-dichlorophenoxy)propyl] amino]ethanol in correlation with activation of ERK.

Zhu H, Zhang L, Wu S, Teraishi F, Davis JJ, Jacob D, Fang B. Zhu H, et al. Oncogene. 2004 Jun 24;23(29):4984-92. doi: 10.1038/sj.onc.1207645. Oncogene. 2004. PMID: 15122344

5

Suppressing orthotopic pancreatic tumor growth with a fiber-modified adenovector expressing the TRAIL gene from the human telomerase reverse transcriptase promoter.

Jacob D, Davis J, Zhu H, Zhang L, Teraishi F, Wu S, Marini FC 3rd, Fang B. Jacob D, et al. Clin Cancer Res. 2004 May 15;10(10):3535-41. doi: 10.1158/1078-0432.CCR-03-0512. Clin Cancer Res. 2004. PMID: 15161713

6

Suppression of pancreatic tumor growth in the liver by systemic administration of the TRAIL gene driven by the hTERT promoter.

Jacob D, Davis JJ, Zhang L, Zhu H, Teraishi F, Fang B. Jacob D, et al. Cancer Gene Ther. 2005 Feb;12(2):109-15. doi: 10.1038/sj.cgt.7700773. Cancer Gene Ther. 2005. PMID: 15486557

7

Fiber-modified adenoviral vector expressing the tumor necrosis factor-related apoptosis-inducing ligand gene from the human telomerase reverse transcriptase promoter induces apoptosis in human hepatocellular carcinoma cells.

Jacob D, Schumacher G, Bahra M, Davis J, Zhu HB, Zhang LD, Teraishi F, Neuhaus P, Fang BL. Jacob D, et al. World J Gastroenterol. 2005 May 7;11(17):2552-6. doi: 10.3748/wjg.v11.i17.2552. World J Gastroenterol. 2005. PMID: 15849810 Free PMC article.

8

Gene therapy in colon cancer cells with a fiber-modified adenovector expressing the TRAIL gene driven by the hTERT promoter.

Jacob D, Bahra M, Schumacher G, Neuhaus P, Fang B. Jacob D, et al. Anticancer Res. 2004 Sep-Oct;24(5A):3075-9. Anticancer Res. 2004. PMID: 15517918 Free article.

9

Combination therapy of poly (ADP-ribose) polymerase inhibitor 3-aminobenzamide and gemcitabine shows strong antitumor activity in pancreatic cancer cells.

Jacob DA, Bahra M, Langrehr JM, Boas-Knoop S, Stefaniak R, Davis J, Schumacher G, Lippert S, Neumann UP. Jacob DA, et al. J Gastroenterol Hepatol. 2007 May;22(5):738-48. doi: 10.1111/j.1440-1746.2006.04496.x. J Gastroenterol Hepatol. 2007. PMID: 17444865

10

Resistance to activated protein C caused by factor V Leiden mutation and orthotopic liver transplantation.

Loew A, Jacob D, Neuhaus P, Riess H. Loew A, et al. Transplantation. 2005 May 27;79(10):1422-7. doi: 10.1097/01.tp.0000158021.66004.19. Transplantation. 2005. PMID: 15912114

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

90 results

Search Page

Filters